Palatin Technologies’ CEO Discusses F2Q2014 Results – Earnings Call Transcript

[at Seeking Alpha] – Steve Wills Thank you, Carl, and good morning, everyone. Regarding operational highlights pivotal Phase 3 clinical trials of Bremelanotide for the treatment of female sexual dysfunction are anticipated … more

View todays social media effects on PTN

View the latest stocks trending across Twitter. Click to view dashboard

See who Palatin is hiring next, click here to view